The nationwide opioid addiction epidemic was in large part boosted by the surgeons’ liberal practice of prescribing opioids for perioperative pain control in the 1990s [1]. In the United States alone, an estimated 500,000 people died between 1999–2019 from opioid overdose [2]. Historically, opium has been used as part of sleep-inducing sponges (“spongia somnifera”) for pain control during surgical procedures as far back as in the medieval times [3]. Prior to the introduction of anesthesia for surgical procedures, it was not uncommon for patients to succumb to the shock induced by surgical pain. With the discovery of volatile anesthetics in the nineteenth century, surgeons were finally able to perform procedures on patients who were unresponsive to the surgical pain [4]. At present, there are two main techniques for delivering general anesthesia: volatile/inhaled anesthesia and total intravenous anesthesia [5]. Opioids were introduced to the anesthesia practice as a method of decreasing the amount of volatile anesthetic necessary for surgical anesthesia, thereby decreasing the risk of toxic side effects from volatile agents [4]. Opioids work synergistically with volatile anesthetics and also provide essential analgesic benefits [6]. The morphine-like opioids used in general anesthesia provide analgesia by binding to mu (μ) receptors [7]. Mu receptor agonism is associated with significant perioperative side effects, including respiratory depression, postoperative nausea/vomiting, constipation, and altered immunomodulatory signaling pathways [7]. Traditionally, the unfavorable side effect profile of morphine-like opioids has been tolerated as a necessary “collateral damage” of general anesthesia, and the management of these side effects has represented a routine part of perioperative care [8]. These traditional standards of opioid-based pain control during surgery and postoperative care have only recently been challenged in response to the recognition of the “iatrogenic” root cause of the widespread opioid addiction epidemic in the twenty-first century [2]. The “Enhanced Surgical Recovery” (ESR) protocol represents a modern streamlined approach designed to optimize the patients’ surgical care by reducing the use of opioids during the perioperative phase in favor of multimodal perioperative pain management protocols [9].
The intuitive next frontier for streamlining our patients’ perioperative care and improving surgical patient safety and patient outcomes is represented by the proactive (and arguably provocative) concept of opioid-free anesthesia. The primary goal of opioid-free anesthesia is to abstain from the use of mu receptor agonists through the use of non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, lidocaine, dexmedetomidine, ketamine, and low-dose glucocorticoids. In addition, regional nerve blocks represent a fundamental pillar of intra- and postoperative analgesia as part of the opioid-free anesthesia protocol [10]. Dexmedetomidine is a selective α2-adrenergic receptor agonist with sedative and analgesic properties. The concept of dexmedetomidine-based anesthesia leverages the benefits of the multimodal pain control strategy in the perioperative arena to decrease both peripheral and central sensitization [11]. Notably, this new modality of general anesthesia has been shown to significantly reduce opioid consumption in patients undergoing bariatric surgery [12], pancreatic surgery [13], major urological procedures [14], rotator cuff repair [15], and total hip replacement [16]. A recent randomized controlled trial in gynecological surgery furthermore corroborated that opioid-free anesthesia was associated with significant improvement in postoperative analgesia, compared to traditional opioid-based anesthesia [17]. At our own institution, opioid-free anesthesia represents the modality of choice for reducing the risks associated with traditional opioid-based anesthesia.
Table 1 outlines the respective medications and dosage ranges for opioid-based vs. opioid-free anesthesia. The first author has a 6-year personal experience with opioid-free anesthesia and delivered the proof-of-concept that this proactive concept is indeed feasible, safe, and effective in providing general anesthesia for all surgical procedures (Jason McLott, unpublished observations). Considering the fact that more than 200 million surgeries are performed world-wide every year [18], the new proactive concept of opioid-free anesthesia likely represents the next frontier for surgical patient safety on a global scale.
Availability of data and materials
Please contact the authors for data requests.
References
Centers for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers—United States 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487–92.
Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019. MMWR Morb Mortal Wkly Rep. 2021;70:202–7.
Prioreschi P. Medieval anesthesia - the spongia somnifera. Med Hypotheses. 2003;61(2):213–9.
Torri G. Inhalation anesthetics: a review. Minerva Anestesiol. 2010;76(3):215–28.
Riedel B, Dubowitz J, Yeung J, Jhanji S, Kheterpal S, Avidan MS. On the horns of a dilemma: choosing total intravenous anaesthesia or volatile anaesthesia. Br J Anaesth. 2022;129(3):284–9.
James A, Williams J. Basic opioid pharmacology - an update. Br J Pain. 2020;14(2):115–21.
Pasternak GW, Pan YX. Mu opioids and their receptors: evolution of a concept. Pharmacol Rev. 2013;65(4):1257–317.
Sutherland AM, Clarke HA. The role of anesthesiologists in reducing opioid harm. Can J Anaesth. 2022;69(8):917–22.
Ljungqvist O, Francis NK, Urman RD. Enhanced recovery after surgery: a complete guide to optimizing outcomes. 1st ed. Switzerland: Springer; 2020. p. 677.
Chia PA, Cannesson M, Bui CCM. Opioid free anesthesia: feasible? Curr Opin Anaesthesiol. 2020;33(4):512–7.
Cao J, Xue FS, Xiao YG, Tian T. Comparing postoperative analgesic efficacy of adding ketamine, dexmedetomidine and lidocaine to multimodal regimen. J Perianesth Nurs. 2022;37(5):586–7.
Berlier J, Carabalona JF, Tete H, Bouffard Y, Le-Goff MC, Cerro V, Abrard S, Subtil F, Rimmele T. Effects of opioid-free anesthesia on postoperative morphine consumption after bariatric surgery. J Clin Anesth. 2022;81:110906.
Hublet S, Galland M, Navez J, Loi P, Closset J, Forget P, Lafere P. Opioid-free versus opioid-based anesthesia in pancreatic surgery. BMC Anesthesiol. 2022;22(1):9.
Smith SA, Ghabra H, Dhaifallah DG, Rahnema A, Evans BM, Nossaman BD, Sumrall WD, Bardot SF, Canter DJ. Novel opiate-free anesthetic technique for major urologic procedures. South Med J. 2020;113(10):499–504.
Theosmy EG, Bradian AK, Cheesman QT, Radack TM, Lazarus MD, Austin LS. Opioid-free arthroscopic rotator cuff repair. Orthopedics. 2021;44(2):e301–5.
Urvoy B, Aveline C, Belot N, Catier C, Beloeil H. Opioid-free anaesthesia for anterior total hip replacement under general anaesthesia: the observational prospective study of opiate-free anesthesia for anterior total hip replacement trial. Br J Anaesth. 2021;126(4):e136–9.
Chen J, Luo Q, Huang S, Jiao J. Effect of opioid-free anesthesia on postoperative analgesia after laparoscopic gynecologic surgery. Minerva Anestesiol. 2022;88(6):439–47.
Stahel PF, Mauffrey C, Butler N. Current challenges and future perspectives for patient safety in surgery. Patient Saf Surg. 2014;8(1):9.
FDA clearance
Not applicable (Editorial).
Funding
There were no external funding sources for this editorial.
Author information
Authors and Affiliations
Contributions
P.F.S. designed the editorial and revised the final manuscript. J.M. wrote the first draft of the article. Both authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable (Editorial).
Consent for publication
Not applicable (Editorial).
Competing interests
Dr. Stahel is the Editor-in-Chief of Patient Safety in Surgery. Both authors are employed by HCA Healthcare. The views expressed in this editorial exclusively represent the authors’ personal perspective and do not necessarily represent official views of HCA Healthcare or any of its affiliated entities. The authors declare no other conflicts of interest related to this editorial.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
McLott, J., Stahel, P.F. Opioid-free anesthesia: the next frontier in surgical patient safety. Patient Saf Surg 16, 38 (2022). https://doi.org/10.1186/s13037-022-00346-5
Published:
DOI: https://doi.org/10.1186/s13037-022-00346-5